YOLFTbeta
Médica Sur S.A.B. de C.V

Médica Sur S.A.B. de C.V

MEDICAB · MX · Healthcare / Medical Care Facilities

54.00MXN+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close54.00
Open54.00
Day Range54.00 – 54.00
52-Week Range45.79 – 62.50
Volume226
Market Cap4.93B
P/E (TTM)0.00
Forward P/E14.16
EPS-0.30
Dividend Yield2.96%
Beta0.28
50-Day Avg55.71
200-Day Avg58.88

About

Médica Sur, S.A.B. de C.V. operates as a healthcare hospital in Mexico. The company offers hospital services such as Surgical units; central operating rooms, gynecology and obstetrics operating rooms, and short-stay surgery; intensive care unit, intermediate care unit, and the coronary care unit; emergency department includes adult and pediatric care; hospital wards; blood bank; and pathological anatomy. It also provides clinical and diagnostic services such as comprehensive cancer center, radiotherapy unit, scalpel-free radiosurgery unit gamma knife, gastroenterology, hepatology and endoscopy, advanced urology, center for neurology and neurosurgery, neurophysiology, rehabilitation medicine, comprehensive diagnostic and treatment center, imaging unit, hemodynamics, magnetic resonance imaging unit, positron emission tomography, nuclear medicine unit, clinical pathology laboratory, and vascular clinic. In addition, the company operates hotel, hemodialysis clinic, medical offices, restaurants and cafes, pharmacies, banking institutions, and parking services. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. operates as a subsidiary of Neuco, SA de CV.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Octavio Gonzalez Chon
  • Employees2.22K
  • HeadquartersPuente de Piedra No. 150, Mexico City, DF, Mexico, 14050, Mexico
  • Websitehttps://www.medicasur.com.mx

Leadership

  • Dr. Octavio Gonzalez ChonDirector General & Director
  • Engineer Juan Francisco Ahedo RozadaDirector of Finance & Administration
  • Dr. Jose Manuel Correa RoveloDirector of Operations & Director
  • Arely GutierrezDeputy Director of Financing & Investor Relations
  • Lic. Moises Francisco Jose Ramos GonzalezSecretary & Legal Director
  • Engineer Juan Antonio Chavez NievesDirector of Human Resources
  • Dr. Martha Helena Ramos OstosDirector of the Center for Clinical Diagnosis & Imaging and Executive Director
  • Dr. Salvador Oscar Rivero BoschertExecutive Director
  • Dr. Sandra Maria Del Carmen Garcia LopezDirector of Medicine & Hospitalization
  • Lic. Concepcion Guadalupe Arriaga Ruiloba Esq.Director of Internal Communications Events

Financials

Income Statement

Currency: MXN2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue621.03M690.36M788.68M848.50M940.02M1.06B1.22B1.38B1.54B1.77B1.80B1.90B2.09B2.26B2.29B2.28B2.59B3.43B3.61B3.70B4.47B3.91B3.87B4.13B4.40B4.79B
Growth (%)-+11.16%+14.24%+7.58%+10.79%+12.47%+15.79%+13.00%+11.59%+14.72%+1.86%+5.37%+9.95%+7.96%+1.58%-0.58%+13.67%+32.47%+5.13%+2.51%+20.77%-12.54%-0.98%+6.77%+6.61%+8.77%
Cost of Revenue275.42M294.96M344.31M435.18M511.28M591.72M676.36M770.97M878.87M1.02B1.06B1.20B1.27B1.32B1.38B1.57B1.79B2.27B2.49B2.61B2.74B2.37B2.50B2.67B2.91B3.07B
Gross Profit-------------828.06M790.73M709.48M795.94M1.16B1.12B1.09B1.72B1.54B1.37B1.46B1.49B1.72B
Gross Margin-------------36.70%34.50%31.13%30.73%33.89%31.07%29.54%38.58%39.30%35.35%35.34%33.88%35.84%
Operating Expense-------------319.13M329.05M368.32M581.69M621.00M689.01M702.82M734.90M778.03M798.12M868.59M923.43M913.75M
Operating Income152.54M167.13M207.72M203.42M204.91M234.43M268.08M288.09M302.31M372.57M357.77M323.19M404.20M508.93M461.68M341.15M214.25M541.90M431.90M389.75M988.11M757.06M569.06M591.04M568.18M802.39M
Operating Margin24.56%24.21%26.34%23.97%21.80%22.17%21.90%20.83%19.58%21.04%19.83%17.00%19.34%22.55%20.14%14.97%8.27%15.79%11.97%10.54%22.12%19.38%14.71%14.31%12.90%16.76%
EBITDA-----------------738.96M640.41M721.14M1.31B995.97M922.80M995.51M863.90M1.11B
EBITDA Margin-----------------21.53%17.75%19.50%29.37%25.50%23.86%24.11%19.62%23.13%
Net Income38.41M72.95M104.44M112.32M131.83M144.46M194.21M216.28M193.67M236.76M231.26M224.03M300.51M379.76M349.08M241.02M142.63M231.80M169.30M140.55M558.83M1.15B949.80M634.98M461.51M540.25M
Net Income Margin6.18%10.57%13.24%13.24%14.02%13.66%15.86%15.63%12.55%13.37%12.82%11.79%14.38%16.83%15.23%10.58%5.51%6.76%4.69%3.80%12.51%29.56%24.56%15.38%10.48%11.28%
Interest Expense000000000000000000144.59M173.11M176.13M78.80M75.95M75.38M75.58M106.20M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.01%4.68%3.94%2.02%1.96%1.83%1.72%2.22%

Balance Sheet

Currency: MXN2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.01B989.72M1.07B1.20B1.39B1.56B1.70B1.99B2.43B2.81B2.80B3.03B3.36B3.34B3.65B3.77B5.46B5.60B5.46B5.85B6.28B6.98B4.58B4.13B4.41B4.78B
Total Liabilities522.23M443.77M414.25M428.43M488.19M527.61M483.43M574.51M889.06M1.10B919.05M855.58M768.98M578.15M542.75M527.87M2.15B2.16B1.92B2.16B2.27B2.07B2.05B2.09B2.07B2.25B
Total Equity347.21M545.95M659.69M772.40M900.78M1.03B1.21B1.41B1.54B1.72B1.88B2.17B2.59B2.76B3.11B3.24B3.30B3.45B3.54B3.68B4.01B4.91B2.52B2.04B2.34B2.52B
Cash65.11M63.24M90.52M27.15M21.57M16.80M27.72M8.24M246.68M113.99M102.99M374.22M250.60M176.25M344.18M359.13M104.31M116.24M171.37M277.23M572.84M3.53B1.22B704.74M1.12B1.55B
Net Debt-----------------1.26B954.84M946.30M436.21M--291.55M--

Cash Flow

Currency: MXN2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow98.67M149.98M173.97M153.15M254.84M230.75M311.87M305.42M306.19M427.75M316.39M349.72M344.11M494.10M474.58M327.81M198.78M213.91M305.90M584.58M1.10B820.94M270.09M606.89M662.36M968.99M
Investing Cash Flow--------------208.60M-297.51M-212.22M-1.66B-83.92M-23.68M-332.17M-112.44M2.56B732.85M---
Financing Cash Flow221.80M-------201.56M-----359.84M-9.14M-100.63M1.20B-17.59M-327.55M-146.55M-693.08M-421.60M-3.31B---
Capital Expenditure29.22M44.71M53.26M124.00M211.12M193.50M194.88M275.56M102.77M244.54M98.33M90.52M3.35M216.61M316.69M228.36M230.33M266.08M179.91M134.67M128.51M150.79M144.39M213.64M136.58M166.21M
Free Cash Flow------------------52.09M125.99M288.10M972.80M670.53M270.09M540.37M662.36M802.78M
Dividends Paid11.46M15.63M19.86M25.50M43.54M45.96M52.84M61.97M61.92M60.68M64.42M64.02M67.56M189.75M9.14M100.63M80.73M82.14M72.98M1.23M185.76K161.68M3.02B778.21M151.10M147.02M
FCF to OCF------------------24.35%41.19%49.28%88.34%81.68%100.00%89.04%100.00%82.85%
Dividend Paid to FCF------------------157.67%57.93%0.43%0.02%24.11%1118.12%144.01%22.81%18.31%

Earnings

Report DateMay 2, 2012Oct 26, 2012Feb 27, 2013Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Feb 27, 2017May 2, 2017Jul 28, 2017Nov 28, 2017Feb 26, 2018Mar 31, 2018Jul 27, 2018Sep 30, 2018Feb 27, 2019May 2, 2019Jul 26, 2019Oct 25, 2019Feb 21, 2020May 25, 2020Jul 28, 2020Oct 27, 2020Feb 22, 2021Apr 26, 2021Jul 15, 2021Oct 21, 2021Feb 21, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Feb 17, 2023Apr 14, 2023Jul 28, 2023Oct 19, 2023Feb 29, 2024Apr 26, 2024Jul 26, 2024Oct 28, 2024Feb 18, 2025Apr 29, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------
EPS Actual0.650.610.720.910.520.660.990.880.570.830.560.530.560.430.520.760.580.28-0.350.400.450.290.720.390.410.410.230.300.330.200.400.400.361.472.512.361.552.005.001.484.621.391.501.571.572.391.991.521.031.521.691.781.701.561.751.771.55
Surprise---------------------------------------------------------
TimingAfter-hoursAfter-hoursPre-market---------------Pre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-market-After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-----

Key Statistics & Ratios

Market Cap4.93B
Enterprise Value4.50B
Trailing P/E0.00
Forward P/E14.16
PEG Ratio0.00
Price / Sales1.04
Price / Book1.91
EPS-0.30
Book Value24.39
Revenue (TTM)4.74B
Gross Profit (TTM)1.60B
EBITDA931.44M
Profit Margin10.85%
Operating Margin15.01%
Return on Equity20.17%
Return on Assets10.03%
Shares Outstanding91.33M
Shares Float107.70M
Beta0.28
Dividend Yield2.96%
Dividend Rate1.60
Payout Ratio24.14%

Dividends

20261×
1.60Jun 2, 2026
20251×
1.50May 19, 2025
20241×
1.50May 14, 2024
20231×
6.53May 30, 2023
20222×
26.83Sep 5, 20222.21May 23, 2022
20211×
1.50May 19, 2021
20182×
0.30Oct 25, 20180.30May 21, 2018
20171×
0.70May 8, 2017
20161×
0.68May 3, 2016
20151×
0.85Apr 23, 2015
20132×
0.84Dec 20, 20130.86Apr 26, 2013
20121×
0.55May 9, 2012
20111×
0.58May 13, 2011
20101×
0.58May 6, 2010
20091×
0.54May 18, 2009
20081×
0.54May 19, 2008
20071×
0.51May 10, 2007
20061×
0.43May 16, 2006
20051×
0.38May 25, 2005
20041×
0.36May 26, 2004
20031×
0.21Jun 26, 2003

Stock Splits

  • Jun 14, 2011273:272